Updates on Extracorporeal CO2 Removal – May 2014
The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS.
This user report by Pr. Gilles Capellier and Dr. Loic Barrot describes the use of the Hemolung RAS to enable lung protection in a ventilated patient with a persistent air leak. The report describes the case of a 45 year old male who was admitted to a peripheral hospital in respiratory distress, where he was diagnosed with a tuberculosis infection, pulmonary embolism (PE), and pneumothorax.
ECCO2R at EURO-ELSO
There will be numerous presentations on ECCO2R at this week’s EURO-ELSO meeting in Paris. Sessions on ECCO2R will take place on Friday, May 23rd from 11:00–12:45 and from 13:00–14:00.
We invite you to learn more about ECCO2R with the Hemolung RAS at our booth (2) in the main exhibit hall.
Date: Friday 23rd May, 2014
Time: 13:00 – 14:00
Location: Soutine & Utrillo Room
We are honored to have the Hemolung RAS recognized as a finalist for the 2014 MDEA Awards. This admission is the result of more than 10 years of dedication and perseverance on the part of our staff, investors, and clinical collaborators who all share a common vision: A better future for patients suffering from acute respiratory failure.